FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146875154> ?p ?o ?g. }

• W2146875154 endingPage "1045" @default.
• W2146875154 startingPage "1036" @default.
• W2146875154 abstract "Prior studies indicate psychiatric symptoms such as depression, apathy and anxiety are risk factors for or prodromal symptoms of incipient Alzheimer’s disease. The study of persons at 50% risk for inheriting autosomal dominant Alzheimer’s disease mutations allows characterization of these symptoms before progressive decline in a population destined to develop illness. We sought to characterize early behavioural features in carriers of autosomal dominant Alzheimer’s disease mutations. Two hundred and sixty-one persons unaware of their mutation status enrolled in the Dominantly Inherited Alzheimer Network, a study of persons with or at-risk for autosomal dominant Alzheimer’s disease, were evaluated with the Neuropsychiatric Inventory-Questionnaire, the 15-item Geriatric Depression Scale and the Clinical Dementia Rating Scale (CDR). Ninety-seven asymptomatic (CDR = 0), 25 mildly symptomatic (CDR = 0.5), and 33 overtly affected (CDR > 0.5) autosomal dominant Alzheimer’s disease mutation carriers were compared to 106 non-carriers with regard to frequency of behavioural symptoms on the Neuropsychiatric Inventory-Questionnaire and severity of depressive symptoms on the Geriatric Depression Scale using generalized linear regression models with appropriate distributions and link functions. Results from the adjusted analyses indicated that depressive symptoms on the Neuropsychiatric Inventory-Questionnaire were less common in cognitively asymptomatic mutation carriers than in non-carriers (5% versus 17%, P = 0.014) and the odds of experiencing at least one behavioural sign in cognitively asymptomatic mutation carriers was lower than in non-carriers (odds ratio = 0.50, 95% confidence interval: 0.26–0.98, P = 0.042). Depression (56% versus 17%, P = 0.0003), apathy (40% versus 4%, P < 0.0001), disinhibition (16% versus 2%, P = 0.009), irritability (48% versus 9%, P = 0.0001), sleep changes (28% versus 7%, P = 0.003), and agitation (24% versus 6%, P = 0.008) were more common and the degree of self-rated depression more severe (mean Geriatric Depression Scale score of 2.8 versus 1.4, P = 0.006) in mildly symptomatic mutation carriers relative to non-carriers. Anxiety, appetite changes, delusions, and repetitive motor activity were additionally more common in overtly impaired mutation carriers. Similar to studies of late-onset Alzheimer’s disease, we demonstrated increased rates of depression, apathy, and other behavioural symptoms in the mildly symptomatic, prodromal phase of autosomal dominant Alzheimer’s disease that increased with disease severity. We did not identify any increased psychopathology in mutation carriers over non-carriers during the presymptomatic stage, suggesting these symptoms result when a threshold of neurodegeneration is reached rather than as life-long qualities. Unexpectedly, we found lower rates of depressive symptoms in cognitively asymptomatic mutation carriers." @default.
• W2146875154 created "2016-06-24" @default.
• W2146875154 creator A5002183686 @default.
• W2146875154 creator A5017017613 @default.
• W2146875154 creator A5018751073 @default.
• W2146875154 creator A5024435882 @default.
• W2146875154 creator A5032450718 @default.
• W2146875154 creator A5032754420 @default.
• W2146875154 creator A5033314636 @default.
• W2146875154 creator A5047385288 @default.
• W2146875154 creator A5047929315 @default.
• W2146875154 creator A5050974013 @default.
• W2146875154 creator A5051059746 @default.
• W2146875154 creator A5058164127 @default.
• W2146875154 creator A5059777306 @default.
• W2146875154 creator A5060487287 @default.
• W2146875154 creator A5063630764 @default.
• W2146875154 creator A5068373508 @default.
• W2146875154 creator A5069522863 @default.
• W2146875154 creator A5070965110 @default.
• W2146875154 creator A5071364728 @default.
• W2146875154 creator A5077632970 @default.
• W2146875154 creator A5087306024 @default.
• W2146875154 date "2015-02-14" @default.
• W2146875154 modified "2023-10-16" @default.
• W2146875154 title "Early behavioural changes in familial Alzheimer’s disease in the Dominantly Inherited Alzheimer Network" @default.
• W2146875154 cites W1551347368 @default.
• W2146875154 cites W1591266288 @default.
• W2146875154 cites W1970331959 @default.
• W2146875154 cites W1971351343 @default.
• W2146875154 cites W1976452134 @default.
• W2146875154 cites W1984972704 @default.
• W2146875154 cites W1990344555 @default.
• W2146875154 cites W1994184254 @default.
• W2146875154 cites W1996053420 @default.
• W2146875154 cites W2000397440 @default.
• W2146875154 cites W2002414308 @default.
• W2146875154 cites W2003061822 @default.
• W2146875154 cites W2004061123 @default.
• W2146875154 cites W2025594724 @default.
• W2146875154 cites W2043297459 @default.
• W2146875154 cites W2058161128 @default.
• W2146875154 cites W2062698830 @default.
• W2146875154 cites W2064184541 @default.
• W2146875154 cites W2066394638 @default.
• W2146875154 cites W2076917672 @default.
• W2146875154 cites W2088361570 @default.
• W2146875154 cites W2105121811 @default.
• W2146875154 cites W2105376855 @default.
• W2146875154 cites W2107381357 @default.
• W2146875154 cites W2108335346 @default.
• W2146875154 cites W2108474398 @default.
• W2146875154 cites W2111963393 @default.
• W2146875154 cites W2112519660 @default.
• W2146875154 cites W2122813545 @default.
• W2146875154 cites W2129497119 @default.
• W2146875154 cites W2135244252 @default.
• W2146875154 cites W2139238476 @default.
• W2146875154 cites W2144021643 @default.
• W2146875154 cites W2148080316 @default.
• W2146875154 cites W2152692871 @default.
• W2146875154 cites W2154416694 @default.
• W2146875154 cites W2160776412 @default.
• W2146875154 cites W2165441361 @default.
• W2146875154 cites W2167326278 @default.
• W2146875154 cites W2171250577 @default.
• W2146875154 cites W2619097621 @default.
• W2146875154 doi "https://doi.org/10.1093/brain/awv004" @default.
• W2146875154 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4963801" @default.
• W2146875154 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25688083" @default.
• W2146875154 hasPublicationYear "2015" @default.
• W2146875154 type Work @default.
• W2146875154 sameAs 2146875154 @default.
• W2146875154 citedByCount "61" @default.
• W2146875154 countsByYear W21468751542015 @default.
• W2146875154 countsByYear W21468751542016 @default.
• W2146875154 countsByYear W21468751542017 @default.
• W2146875154 countsByYear W21468751542018 @default.
• W2146875154 countsByYear W21468751542019 @default.
• W2146875154 countsByYear W21468751542020 @default.
• W2146875154 countsByYear W21468751542021 @default.
• W2146875154 countsByYear W21468751542022 @default.
• W2146875154 countsByYear W21468751542023 @default.
• W2146875154 crossrefType "journal-article" @default.
• W2146875154 hasAuthorship W2146875154A5002183686 @default.
• W2146875154 hasAuthorship W2146875154A5017017613 @default.
• W2146875154 hasAuthorship W2146875154A5018751073 @default.
• W2146875154 hasAuthorship W2146875154A5024435882 @default.
• W2146875154 hasAuthorship W2146875154A5032450718 @default.
• W2146875154 hasAuthorship W2146875154A5032754420 @default.
• W2146875154 hasAuthorship W2146875154A5033314636 @default.
• W2146875154 hasAuthorship W2146875154A5047385288 @default.
• W2146875154 hasAuthorship W2146875154A5047929315 @default.
• W2146875154 hasAuthorship W2146875154A5050974013 @default.
• W2146875154 hasAuthorship W2146875154A5051059746 @default.
• W2146875154 hasAuthorship W2146875154A5058164127 @default.
• W2146875154 hasAuthorship W2146875154A5059777306 @default.
• W2146875154 hasAuthorship W2146875154A5060487287 @default.

• next